Long-term assessment of interferon responses in the HIV+ and AIDS patients

Archivum Immunologiae et Therapiae Experimentalis

Volumn 44, Issue 5-6, 1996, Pages 345-352

  Piasecki, Egbert ^a   Knysz, Brygida ^b   Inglot, Małgorzata ^b   Simon, Krzysztof ^b   Gładysz, Andrzej ^b  

^a INSTITUTE OF IMMUNOLOGY AND EXPERIMENTAL THERAPY   (Poland)

^b MEDICAL UNIVERSITY OF LUBLIN   (Poland)

Author keywords

HIV progression marker; HIV positive patients; interferon induction; interferons

Indexed keywords

ALPHA INTERFERON; GAMMA INTERFERON; INTERFERON; PHYTOHEMAGGLUTININ; ZIDOVUDINE;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ADULT; ARTICLE; CLINICAL ARTICLE; FEMALE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INTERFERON PRODUCTION; MALE; NEWCASTLE DISEASE PARAMYXOVIRUS;

ACQUIRED IMMUNODEFICIENCY SYNDROME; ADULT; CD4 LYMPHOCYTE COUNT; CELLS, CULTURED; DISEASE PROGRESSION; FEMALE; FOLLOW-UP STUDIES; HIV SEROPOSITIVITY; HUMANS; INTERFERON INDUCERS; INTERFERON TYPE II; INTERFERON-ALPHA; LEUKOCYTES; MALE; NEWCASTLE DISEASE VIRUS; PHYTOHEMAGGLUTININS;

EID: 0029843230     PISSN: 0004069X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (34)

1. ANKEL H., CAPOBIANCHI M. R., CASTILLETTI C. and DIANZANI F. (1994): Interferon induction by HIV glycoprotein 120: role of the V3 loop. Virology, 205, 34-43.
2. BALLEARI E., TIMITILLI S., BASON C., PUPPO F., MASSA G., BRENCI S., INDIVERI F. and GHIO R. (1995): Altered production of cytokines modulating hematopoiesis by cultured T lymphocytes of subjects with human immunodeficiency virus (HIV) infection. Fund. Clin. Immunol., 3, 123-130.
3. BARCELLINI W., RIZZARDI G. P., BORGHI M. O., FAIN C., LAZZARIN A. and MERONI P. L. (1994): TH1 and TH2 cytokine production by peripheral blood mononuclear cells from HIV-infected patients. AIDS, 8, 757-762.
4. BARCELLINI W., RIZZARDI F. P., VELATI C., BORGHI M. O., FAIN C., LAZZARIN A. and MERONI P. L. (1995): In vitro production of type 1 and type 2 cytokines by peripheral blood mononuclear cells from high-risk HIV-negative intravenous drug users. AIDS, 9, 691-694.
5. BERG K., HANSEN M. B. and NIELSEN S. E. (1990): A new sensitive bioassay for precise quantification of interferon activity as measured via the mitochondrial dehydrogenase function in cells (MTT method). APMIS, 98, 156-162.
6. BUIMOVICI K. E., LANGE M., KLEIN R. J., GRIECO M. H. and GOOPER L. Z. (1986): Long-term follow-up of serum-interferon and its acid-stability in a group of homosexual men. AIDS Res., 2, 99-108.
7. CAPOBIANCHI M. R., AMEGLIO F., CORDIALI FEI P., CASTILLETTI C., MERCURI F., FAIS S. and DIANZANI F. (1993): Coordinate induction of interferon α and γ by recombinant HIV-1 glycoprotein 120. AIDS Res. Hum. Retroviruses, 9, 957-962.
8. CAPOBIANCHI M. R., DE MARCO F., DI MARCO P. and DIANZANI F. (1988): Acid-labile human interferon alpha production by peripheral blood mononuclear cells stimulated by HIV-infected cells. Arch. Virol., 99, 9-19.
9. Centers for Disease Control (1993): Revised classification system for HIV infection and expanded surveillance case definition for AIDS among adolescent and adult. MMWR, 41, 1-19.
10. H2 switch is a critical step in the etiology of HIV infection. Immunol. Today, 14, 107-111.
11. CLERICI M., VILLA M. L., TRABATTONI D. and SHEARER G. M. (1995): The breakdown of the cytokine network subsequent to human immunodeficiency virus infection. Med. Inflamm., 4, 315-321.
12. DALGLEISH A. G. (1995): The immune response to HIV: potential for immunotherapy? Immunol. Today, 16, 356-358.
13. DANILUK J. and KANDEFER-SZERSZEŃ M. (1994): Interferon production by peripheral blood cells of patients with alcoholic liver disease (ALD). Arch. Immunol. Ther. Exp., 42, 231-238.
14. DESTEFANO E., FRIEDMAN R. M., FRIEDMAN-KIEN A. E., GOEDERT J. J., HENDRIKSEN D., PREBLE O. T., SONNABEND J. A. and VILČEK J. (1982): Acid-labile human leukocyte interferon in homosexual men with Kaposi's sarcoma and lymphadenopathy. J. Infect. Dis., 146, 451-455.
15. EYSTER M. E., GOEDERT J., POON M. C. and PREBLE O. T. (1983): Acid-labile alpha interferon. A possible preclinical marker of the acquired immunodeficiency syndrome in hemophilia. N. Engl. J. Med., 309, 583-586.
16. HANSEN M. B., NIELSEN S. E. and BERG K. (1989): Re-examination and further development of a precise and rapid dye method for measuring cell growth/cell kill. J. Immunol. Methods, 119, 203-210.
17. HOWELL D. M., FELDMAN S. B., KLOSER P. and FITZGERALD-BOCARSLY P. (1994): Decreased frequency of functional natural interferon-producing cells in peripheral blood of patients with the acquired immune deficiency syndrome. Clin. Immunol. Immunopathol., 71, 223-230.
18. HUYGEN K., MASCART-LEMONE F., CRAN S., VAN DE PERRE P., HENRIVAUX P., DE LEY M. and CLUMECK N. (1985): Analysis of the interferon system in African patients with acquired immunodeficiency syndrome. Eur. J. Clin. Microbiol., 4, 304-309.
19. INGLOT A. D., LESZEK J., PIASECKI E. and SYPUŁA A. (1994): Interferon responses in schizophrenia and major depressive disorders. Biol. Psychiatry, 35, 464-473.
20. INGLOT A. D., PIASECKI E., SZULC B., GROEHLICH B., DOBRACKI W., GŁADYSZ A., LESZEK J., SZKLARZ E. and ŚCIBORSKI R. (1988): Assessment of interferon production in patients with chronic nonviral diseases by whole blood or whole bone marrow techniques. Arch. Immunol. Ther. Exp., 36, 439-446.
21. INGLOT A. D., PIASECKI E., ZACZYŃSKA E. and ZIELIŃSKA-JENCZYLIK J. (1992): Seleno-organic compounds induce interferon and tumor necrosis factor in human but not in rat or mouse lymphoid cells. Arch. Immunol. Ther. Exp., 40, 169-173.
22. KIRCHNER H., KLEINICKE C. and DIGEL W. (1982): A whole-blood technique for testing production of human interferon by leukocytes. J. Immunol. Methods, 48, 213-219.
23. LAU A. S., DER S. D., MERRILL J. D. and YEUNG M. C. (1994): Evasion of the interferon-α system in HIV infection. Res. Immunol., 145, 668-673.
24. LEVY J. A. (1993): Pathogenesis of human immunodeficiency virus infection. Microbiol. Rev., 57, 183-289.
25. + T-cell clones in human immunodeficiency virus infection. Blood, 84, 4262-4268.
26. NOKTA M. A. and POLLARD R.B. (1990): Patterns of interferon γ production by peripheral blood mononuclear cells from patients with human immunodeficiency virus infection. J. Interferon Res., 10, 173-181.
27. + patients as markers for monitoring of the AIDS progression. Arch. Immunol. Ther. Exp., 42, 439-445.
28. H2 cytokines in HIV infection. Immunol. Rev., 140, 73-92.
29. ROSSOL S., VOTH R., LAUBENSTEIN H. P., MÜLLER W. E. G., SCHRÖDER H. C., MEYER ZUM BÜSCHENFELDE K.-H. and HESS G. (1989): Interferon production in patients infected with HIV-1. J. Infect. Dis., 159, 815-821.
30. SWINDELLS S., BALDWIN T., KELLY C., BACA-REGEN L., LOOMIS L., POST D., BRICHACEK B., STEVENSON M., DOMINGUEZ E. A., REDDY R., KLEIN R., LIAO M.-J., TESTA D., MCDONALD T., BELLANTI J., SKURKOVICH S. and GENDELMAN H. E. (1996): Regulation and characterization of the interferon-α present in patients with advanced human immunodeficiency virus type 1 disease. J. Interferon Cytokine Res., 16, 127-137.
31. TSOUKAS C. M. and BERNARD N. F. (1994): Markers predicting progression of human immunodeficiency virus-related disease. Clin. Microbiol. Rev., 7, 14-28.
32. VON SYDOW M., SÖNNERBORG A., GAINES H. and STRANNEGARD Ö. (1991): Interferon alpha and tumor necrosis factor-alpha in serum of patients in various stages of HIV-1 infection. AIDS Res. Hum. Retroviruses, 7, 375-380.
33. VOTH R., ROSSOL S., KLEIN K., HESS G., SCHÜTT K. H., SCHRÖDER H. C., MEYER ZUM BÜSCHENFELDE K.-H. and MÜLLER W. E. G. (1990): Differential gene expression of IFN-α and tumor necrosis factor-α in peripheral blood mononuclear cells from patients with AIDS related complex and AIDS. J. Immunol., 144, 970-975.
34. VYAKAMAM A., MATEAR P., MEAGER A., KELLY G., STANLEY B., WELLER I. and BEVERLEY P. (1991): Altered production of tumor necrosis factors alpha and beta and interferon gamma by HIV-infected individuals. Clin. Exp. Immunol., 84, 109-115.